Animal Origin Free Enzymes avoid potential viral risks.
Press Release Summary:
Consisting of AOF Collagenase, recombinant DNase I, RNase T1, and proteases including Neutral Protease, Animal Origin Free Enzymes avoid potential BSE/TSE and mammalian viral risks and regulatory issues associated with bovine and other animal sources. Applications include biopharmaceutical, biomedical, regenerative medicine, and bioprocessing such as isolation of primary and stem cells for autologous transplantation, artificial organ research, and the processing of vaccine components.
Original Press Release:
New Animal Origin Free Enzymes
Worthington Biochemical produces hundreds of different enzymes including several key Animal Origin Free (AOF) products.
These new Animal Origin Free Enzymes include AOF Collagenase, recombinant DNase I, RNase T1 and proteases including Neutral Protease (dispase).
Using AOF Enzymes avoids potential BSE/TSE and mammalian viral risks and regulatory issues associated with bovine and other animal sources.
Applications include biopharmaceutical, biomedical, regenerative medicine and bioprocessing such as the isolation of primary and stem cells for autologous transplantation, artificial organ research and the processing of vaccine components.
As an ISO9001 certified primary manufacturer, Worthington Biochemical can meet enzyme requirements from research-scale to bulk bioprocessing quantities.
To obtain additional information on Worthington Biochemical Animal Origin Free Enzymes, call: 800.445.9603 732.942.1660 or Fax: 732-942-9270. The information may also be obtained at www.worthington-biochem.com or E-mail CustService@worthington-biochem.com
Worthington Biochemical Corp. was founded in 1947 by Charles C. Worthington in Freehold, New Jersey. Over the years, its purpose has been the production of the highest quality enzymes and biochemicals for life science research and bioprocessing applications.
